A call for more comprehensive smoking cessation programs for cancer patients who smoke

October 13, 2020

CHAPEL HILL, N.C.--Programs designed to help cancer patients stop using tobacco should be considered as important and impactful as providing the right drug at the right time and at the right dose to patients, according to researchers at the University of North Carolina Lineberger Comprehensive Cancer Center.

In an editorial published in JAMA, UNC Lineberger's Adam Goldstein, MD, MPH, director of the UNC Tobacco Treatment Programs and professor in the UNC School of Medicine Department of Family Medicine, and his co-authors called for more funding and better reimbursement for smoking cessation counseling for cancer patients who smoke.

Research has shown that providing intensive smoking cessation counseling to newly diagnosed cancer patients who smoke was associated with improved quality of life, fewer complications related to cancer treatments and longer survival. In addition, a study published last year found some cancer treatments were less effective in people who smoke, and this resulted in significantly greater costs for subsequent cancer treatments.

"Since cancer patients often get expensive chemotherapy for months to years to help cure their cancer, six months of inexpensive intensive tobacco cessation support at the time of diagnosis is scientifically proven, common sense and improves all outcomes of cancer care," said Goldstein.

Kimberly Shoenbill, MD, PhD, assistant professor of Family Medicine and a member of the Program on Health and Clinical Informatics at UNC School of Medicine, and Trevor Jolly, MBBS, assistant professor of medicine and UNC Lineberger member, are the editorial's two other authors.

Their editorial accompanied a study by Elyse Park, PhD, and colleagues that compared the impact of an intensive vs standard cancer center smoking cessation intervention, with different levels of intensity and frequency of counseling, support and medications. The study showed patients who completed the study and were part of the intensive treatment group - which had weekly, biweekly and monthly telephone counseling sessions and free cessation medication - achieved higher seven-day abstinence rates at six-month follow-up (34.5%) compared to patients in the standard treatment group (21.5%).

Goldstein said the study demonstrates for the first time the value and necessity of providing intensive smoking cessation counseling, of up to eight sessions per quit attempt, as a standard for cancer care. These findings, he said, should serve as a wake-up call for hospitals, cancer centers, physicians and payers.

"Excellence in cancer care is defined by a great team, delivering great care, with everyone focused on the patient and their family. A great cessation program in cancer centers requires unequivocal buy-in at all levels," Goldstein said. "You cannot have a great cancer hospital today without a great cessation program for cancer patients."

There are a number of challenges that cancer centers may experience in implementing intensive smoking cessation programs. This includes a reluctance by oncologists to provide the intensive counseling - which may be due, in part, to time constraints and lack of smoking cessation training - and insufficient reimbursement for counseling services.

"Medicare, Medicaid and most private insurers usually pay less than $100 for only four total counseling sessions per quit attempt, yet they will readily pay over $100,000 a year for drugs to treat cancer. Current fee-for-service reimbursement does not begin to cover the cost of providing intensive cessation counseling," Goldstein said. This reimbursement model is shortsighted, he noted, because the expense of providing intensive smoking cessation counseling results in immediate cost savings and improved health in the long run.

"For every $1 invested in a cancer center cessation program, $6 in savings from reduced future costs likely occurs, making intensive cessation counseling perhaps the most cost-effective, cheapest and safest cancer treatment currently possible," Goldstein said.

"Health care systems are rapidly changing to value-based care. As payers increasingly track outcomes of care, when they compare patients treated in health care systems that offer intensive cessation counseling that result in patients quitting smoking, compared to systems where they receive neither, the choice is obvious."
-end-


UNC Lineberger Comprehensive Cancer Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.